Observational Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastrointest Oncol. Dec 15, 2014; 6(12): 444-449
Published online Dec 15, 2014. doi: 10.4251/wjgo.v6.i12.444
Table 3 The effect of GNAS1 T393C on distinct carcinomas
AuthorYearCancer typeAllGenotypenOS (%)BenefitP
Alakus2009Gastric cancer122TT2656.9TT0.043
TC5732.7
CC3942.6
Schmitz2007Cholangiocarcinoma87TT1510C+0.04
TC4117
CC3118
Lehnerdt2008Laryngocarcinoma157TT4076TT0.037
TC7549
CC4243.5
Frey2006Chronic lymphocytic leukemia144TT2773T+0.013
TC7263.3
CC4533.2
Vashist2011Esophageal cancer190TT3819CC0.001
TC9615
CC5651
Frey2005Bladder cancer254TT4982TT0.015
TC12160
CC8458
Frey2006Renal cancer150TT3491TT0.01
TC7981
CC3769
Frey2005Colorectal cancer151TT3687.8TT0.009
TC7271
CC4350
Otterbach2007Breast cancer279TT6423CC0.01
TC16240
CC5363
Lehnerdt2008Oral carcinoma202TT4851.3TT0.015
TC8944.7
CC6536.8
Kaderi2008Chronic lymphocytic leukemia279TT8065NS0.802
TC11570
CC8464
Frey2010Malignant melanoma328TT6987.1TT0.017
TC149NS
CC11066
Xie2013Non-small cell131TT33NSTT0.02
lung cancerTC63NS
CC35NS